Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genzir Diagnostics (operating under Genzir Technologies Private Limited) is an Indian healthcare and medical technology company specializing in advanced diagnostic services, medical device development, and regenerative medicine. Founded by Dr. Wasia Rizwani, the company develops point-of-care, sterile, and biocompatible devices such as GenAdipose and GenT2C (SVFeasy) designed to process adipose tissue and isolate stromal vascular fraction (SVF) for autologous stem cell-based therapies. In addition to its medical device portfolio, Genzir operates a diagnostic laboratory in Hyderabad offering routine and specialized clinical testing. The company also conducts research in oncology, focusing on breast cancer progression (specifically the role of Profilin-1) and molecular changes in cervical cancer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genzir Diagnostics.